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Teledermatology for the Diagnosis
andManagement of Skin Cancer
A Systematic Review
Anna Finnane, PhD; Kathy Dallest, GradCertBusAdmin; Monika Janda, PhD; H. Peter Soyer, MD
IMPORTANCE As technology becomesmore commonplace in dermatological practice, it is
essential to continuously review the accuracy of teledermatology devices and services
compared with in-person care. The last systematic reviewwas conducted over 5 years ago.
OBJECTIVE To synthesize and assess the quality of the evidence to address 3 research
questions: (1) How accurate is teledermatology for skin cancer diagnosis compared with usual
care (face-to-face [FTF] diagnosis)? (2) Does teledermatology save clinician and/or patient
time, compared with usual care? (3) What are the enablers and barriers to adoption of
teledermatology in clinical practice for the diagnosis of skin cancer?
EVIDENCE REVIEW The review protocol was registered in the PROSPERO database. Six
databases (Cochrane, PubMed, Medline, Science Direct, Embase, andWeb of Science) were
searched for studies investigating the diagnostic accuracy and concordance, management
accuracy and concordance, measures of time (waiting times, delay to diagnosis), and enablers
and barriers to implementation. Potentially eligible articles were screened by 2 reviewers. The
Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool was used to evaluate
the risk of bias and applicability of individual studies assessing diagnostic accuracy.
FINDINGS Twenty-one studies were reviewed. The diagnostic accuracy (defined as
agreement with histopathology for excised lesions or clinical diagnosis for nonexcised lesions)
of FTF dermatology consultation remains higher (67%-85% agreement with reference
standard, Cohen κ, 0.90) when compared with teledermatology (51%-85% agreement with
reference standard, κ, 0.41-0.63), for the diagnosis of skin cancer. However, some studies do
report high accuracy of teledermatology diagnoses. Most studies of diagnostic accuracy and
concordance had significant methodological limitations. Studies of health service outcomes
found teledermatology reduced waiting times and could result in earlier assessment and
treatment. Patients reported high satisfaction and were willing to pay out of pocket for
access to such services.
CONCLUSIONS AND RELEVANCE Robust implementation studies of teledermatology are
needed, paying careful attention to reducing risk of bias when assessing diagnostic accuracy.
Teledermatology services consistently reduced waiting times to assessment and diagnosis,
and patient satisfaction was high.
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E arly diagnosis and treatment of melanoma and nonmela-noma skin cancers improves prognosis.1 As rates of skincancers increase, there is greater pressure on the derma-
tology workforce in both rural and urban areas. Different forms of
teledermatology have been explored as a solution to this growing
problem.2,3 The 2 most common types of teledermatology
are: store and forward (SAF), involving transfer of images and
clinical information to a dermatologist for review at another
time and location; and live interactive (LI), usually video-
conferencing, which allows real-time interaction between the
clinician and patient.
Before implementing a new mode of medical care like
teledermatology, it is important to ensure that the diagnostic
accuracy is comparable to that of face-to-face (FTF) consulta-
tions, and that patient care is not compromised. For the
diagnosis of skin lesions, this is not straightforward. When a
biopsy is taken the reference standard is the histopathologic
result but when the lesion is considered benign, the clinical diag-
nosis by the dermatologist is accepted as the reference standard.
In 2010, a US study of histopathology discordance in melanoma
diagnosis reported discordant results in 392 (14.3%) cases.4 An
earlier review of diagnostic accuracy in nonmelanoma skin can-
cers reported discordant histopathologic results (studies included
2-77 pathologists) in 2% to 7% of cases.5 These discrepancies in
the “reference standard” have implications for studies of diagnos-
tic accuracy and can also have clinical consequences for
patients.4-6 While histopathology is still the most accurate diag-
nostic method for skin cancers and remains the gold standard, it
is important to take this margin of diagnostic discordance into
account when setting thresholds for acceptable levels of diagnos-
tic accuracy for new diagnostic tests.
A systematic review7 published in 2011 found that the accu-
racy of FTF dermatology was better than SAF teledermatology for
diagnosing skin conditions (weightedmean difference, 11% for pri-
mary, 19% for aggregated diagnostic accuracy). However, the
authors concluded the levels of diagnostic accuracy and concor-
danceofbothSAFandLI teledermatologywerestill acceptablecom-
pared with FTF dermatology.7 Since that time, there has been sig-
nificant growth in the number of devices, software, and systems
marketed for use by dermatologists, ranging from small dermo-
scopic attachments for mobile phones and digital cameras and as-
sociatedmobile applications, to3-dimensional imaging systems for
high resolution full bodyphotography. These technologieshave the
potential to improve access to specialist services, enable earlier di-
agnosis of skin cancers, and provide consumers and clinicians with
away of storing high-quality images of lesions to supportmonitor-
ing of any changes over time.
Five years on, this review is an updated synthesis and critique
of the most recent studies of the use of teledermatology specifi-
cally for the diagnosis and management of skin cancer. We con-
ducted a review of all studies published since June 2009 (cut-off
date for inclusion in the previous review) addressing the following
research questions: (1) How accurate is teledermatology for skin
cancer diagnosis compared to usual care (FTF diagnosis)?
(2) Does teledermatology save clinician and/or patient time,
compared with usual care? (3) Are there barriers to adoption
of teledermatology in clinical practice for the diagnosis of skin
cancer?
Methods
The protocol was registered on PROSPERO International prospec-
tive register of systematic reviews and can be accessed at http:
//www.crd.york.ac.uk/PROSPERO/display_record.asp?ID
=CRD42015014295. The review adheres to the principles of the
PRISMAStatement.ThePRISMAchecklist and inclusioncriteria flow
chart are included in the Supplement.8
Search Strategy
We searched Cochrane, PubMed, Medline, Science Direct,
Embase, and Web of Science databases for systematic reviews
and original research articles, restricted to human research
published in English.
The search terms remote consult, remote consultation, elec-
tronic mail, telecommunications, telemedicine, teledermatology,
dermatology, store and forward, dermoscopy, teledermoscopy,
teledermatoscopy, skin cancer, melanoma, carcinoma, were com-
bined using the appropriate methods for each database.
Study Selection
Studies were included if the primary focus was on the use of
teledermatology or teledermoscopy interventions for diagnosing
or managing melanoma or nonmelanoma skin cancers. Only full
articles were included. Specific exclusion criteria included studies
of teledermatology applications using image analysis software,
case studies and case series, and studies including participants
younger than 18 years.
Quality Assessment
The Quality Assessment of Diagnostic Accuracy (2nd edition,
QUADAS-2) was used to assess risk of bias in studies of diagnostic
accuracy and diagnostic concordance, as well as applicability to
the review question.9 The tool has 4 domains including patient
selection, index test, reference standard, and flow and timing (ie,
patient flow and timing of outcome assessments). In diagnostic
accuracy studies, the index test is the test or intervention being
studied, while the reference standard, otherwise known as the
gold standard is the best available method to determine whether
participants have the condition. Within these 4 domains, signal-
ing questions are used to assess whether the risk of bias is low,
Key Points
Question How accurate is teledermatology for skin cancer
diagnosis compared with face-to-face (FTF) consultation, and
what are the enablers and barriers to implementation in practice?
Findings Diagnostic accuracy of FTF consultation remains higher
for diagnosis of skin cancer compared with teledermatogy.
Teledermatology reduces waiting times and reported patient
satisfaction is high.
Meaning Considering high satisfaction and reduced waiting times
associated with teledermatology, robustly designed studies are
needed to determine whether the level of diagnostic accuracy of
teledermatology is acceptable to be used as an alternative to FTF
consultation.
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high, or unclear, and the applicability to the original review ques-
tion is assessed.9 Applicability to the review question is consid-
ered an important aspect of the quality assessment process; it is
possible that even high-quality, well-designed and reported stud-
ies with low risk of bias, differ from the review question in some
fundamental way that reduces the generalizability of results.
Results of the quality assessment process are presented in
Table 1.
Data Synthesis
Two researchers (A.F. and K.D.) extracted data. The outcomes
related to each review question are defined below:
(1) How accurate is teledermatology for skin cancer diagnosis
compared with usual care (FTF diagnosis)?
Themain outcomes of diagnostic accuracy, diagnostic concor-
dance, management accuracy and management concordance are
defined inTable 2, specifying the relevant reference standard (cur-
rent gold standard) and index test (comparator). Studies of diag-
nostic accuracy were separated into teledermatology and teleder-
moscopy subgroups.
(2) Does teledermatology save clinician and/or patient time,
compared with usual care?
Results relating to any aspects of clinician or patient timewere
extracted. This included time in days between referral and special-
ist consultation, time in days between referral and surgical excision
of the lesions, and Breslow thickness as a proxy measure of de-
layed diagnosis.
(3) What are the enablers and barriers to adoption of teleder-
matology in clinical practice, for the diagnosis of skin cancer?
Results fromall studies that exploredaspectsofpatient andcli-
nician satisfaction and receptivity, feasibility of teledermatology, or
barriers to implementation were synthesized.
Results
The study selectionprocess is detailed in the eFigure in the Supple-
ment. Results from all database searches were combined and du-
plicateswere removed. Titles and abstractswere reviewed and 153
of 241 studieswere excluded for the following reasons: telederma-
tology fordiagnosingormanaging skin cancerwasnot aprimary fo-
cus; study published prior to June 2009; conference abstract only,
or full text not available in English. Of 88 full-text articles assessed,
41 were excluded owing to criteria defined above, and 25 were
published prior to June 2009.
Twenty-eight articlesmet inclusion criteria but 7of 28wereex-
cludedowing to insufficient reportingofmethods toenablequality
assessment.19-25 Characteristics of the 21 included studies are
presented in Table 3.
Diagnostic Accuracy
Eight studies (7 including dermoscopy) reported the diagnostic ac-
curacyof teledermatologyconsultations10,11,17,18,26,27,35,36 (Table4).
Threeof the8studies also assessedaccuracyof FTFdiagnosis com-
pared with histopathological diagnosis, and compared the level of
accuracy for FTF diagnoses with teledermatology diagnoses.11,17,35
Three studies assessing diagnostic accuracy of teledermatol-
ogy using 133 to 188 clinical images (without dermoscopy) re-
ported 68% to 85% agreement between teledermatology
Table 2. Definitions forMain ReviewOutcomes, Reference Standards,
and Index Tests
Study Outcome Reference Standard Index Test
Diagnostic
accuracy
Histopathologic results
(excised lesions) and FTF
diagnosis (nonexcised
lesions)
Teledermatologist
diagnosis or FTF
dermatologist diagnosis
Diagnostic
concordance
FTF dermatologist
diagnosis
Teledermatologist
diagnosis
Management
accuracy
Management plan based
on histopathologic results
(excised lesions) and
management plan based
on FTF results (nonexcised
lesions)
Teledermatologist
prescribed management
plan or FTF dermatologist
prescribed management
plan
Management
concordance
FTF dermatologist
prescribed management
plan
Teledermatologist
prescribed management
plan
Abbreviation: FTF, face-to-face.
Table 1. QUADAS-2 Summary Table
Study
Risk of Bias Applicability Concerns
Patient
Selection
Index
Test
Reference
Standard
Flow and
Timing
Patient
Selection
Index
Test
Reference
Standard
Borve et al,37 2012 Low Low High Unclear Low Low Low
Borve et al,35 2013 High Unclear Low Low Low Low Low
Borve et al,36 2015 Low Low Unclear Low Low Low Low
Congalton et al,10 2015 Low Low Unclear High Low Low Low
Kroemer el al,11 2011 Unclear Unclear Low High Low Low Low
Lamel et al,12 2012 High Low Low Low Low Low Low
Manahan et al,13 2015 High Low Low Low Low Low Low
Massone et al,26 2014 High Low High High High Low Low
Senel et al,14 2015 Low Low Low Low Unclear Low Low
Silveira et al,15 2014 Unclear Low Low Unclear Low High Low
Tan et al,16 2010 Unclear High Low Low Unclear Low Low
Van der Heijden et al,17
2013
Unclear Unclear Unclear Unclear Unclear Low Low
Warshaw et al,7 2015 Unclear Low Low Low High Low Low
Wolf et al,18 2013 High High Low Low High High Low
Abbreviation: QUADAS-2, The Quality
Assessment of Diagnostic Accuracy
Studies.
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Table 3. Study Characteristics
Source Design Population Intervention Outcome
Quality
Ratinga
Studies of diagnostic accuracy and concordance and management accuracy and concordance
Borve et al,37
2012
Prospective
diagnostic
accuracy
Sweden; 40 patients,
23 women, 17 men
(mean age, 49 y)
Teledermatology referrals via MMS
service using mobile phone camera
compared with FTF diagnosis
Diagnostic accuracy;
management
concordance; barriers,
image quality
3
Borve et al,35
2013
Prospective
diagnostic
accuracy
Sweden; 62 patients,
24 women, 38 men
(mean age, 64 y);
69 included lesions
Clinical info and dermoscopic images
uploaded to iDoc24 app and
compared with FTF diagnosis
Diagnostic accuracy;
management accuracy;
barriers, image quality
and diagnostic difficulty
2
Borve et al,36
2015
Open, controlled,
multicenter
prospective
observational
study
Sweden; 20 primary
health care centers,
an urban hospital, and
a rural hospital;
346 referrals
iDoc24 teledermoscopy referral
compared with paper based referral
system
Diagnostic accuracy;
management accuracy;
time
2
Boyce et al,14
2011
Prospective
diagnostic
accuracy
Australia; 55 patients,
22 women, 33 men
(median age, 26 y);
157 lesions
Assessment of mobile phone images
compared with FTF assessment
Management
concordance; barriers,
ease of use
3
Congalton et al,10
2015
Prospective
diagnostic
accuracy
New Zealand; 310 eligible
patients, 54% women,
(median age, 58 y);
613 lesions
Macro and dermoscopic images
captured at molemap clinic and sent
with clinical info
Diagnostic accuracy;
time
3
Kroemer et al,11
2011
Prospective
diagnostic
accuracy
Austria; 88 patients,
47 women, 41 men
(median age, 69 y),
113 lesions
Mobile phone camera and
dermatoscope used to take images
uploaded and compared with FTF
diagnosis
Diagnostic accuracy;
barriers, image quality
3
Lamel et al,12
2012
Prospective
diagnostic
concordance
United States; 86 patients
58% women (mean age,
45.2 y); 137 lesions
Mobile phone images compared with
FTF diagnosis at screening event
Diagnostic concordance;
management
concordance
2
Manahan et al,13
2015
Pilot randomized
clinical trial
Australia; 49 participants,
49% men (ages 50-64 y);
49% with a medical history
of at least 1 skin cancer
Mobile teledermoscopy used by
consumers to submit images for
review; randomized to receive
instructions for self-examination or
not
Management
concordance; barriers,
instructions for
self-examination
2
Massone et al,26
2014
Observational Austria; 690 patients,
48 women, 642 men
(mean age, 47 y);
962 lesions
GPs performing FTF skin checks at a
screening program took macro and
dermoscopic images for
teledermatology assessment
Diagnostic accuracy;
barriers, image quality
3
Senel et al,27
2014
Retrospective
diagnostic
accuracy
Turkey; 120 consecutive
cases, 57% men
(mean age, 63 y)
Medical records and images from
patient archives used to compare
retrospectively FTF diagnosis with
telediagnosis
Diagnostic accuracy;
management
concordance
2
Silveira et al,15
2014
Prospective
diagnostic
accuracy
Brazil; 460 suspicious
lesions from 2592
dermatological
examinations
Images taken at mobile prevention
unit using digital camera, prior to
biopsy, and sent to 2 oncologists for
telediagnosis
Diagnostic concordance;
barriers, image quality
2
Tan et al,16
2010
Prospective
diagnostic
accuracy
New Zealand;
200 patients,
126 women, 74 men
(age, 11-94 y);
491 lesions
Panoramic, macroscopic and
dermoscopic images uploaded to
MoleMap for telediagnosis, compared
with FTF diagnosis
Diagnostic concordance;
barriers, access
2
Tan et al,28
2010
Prospective
diagnostic
accuracy
New Zealand;
206 patients;
979 lesions
Panoramic, macroscopic, and
dermoscopic images uploaded to
MoleMap for telediagnosis by 5
international dermatologists online
Interobserver variability 3
Van der
Heijden et al,17
2013
Prospective
diagnostic
accuracy
Netherlands;
105 patients,
55% women
(mean age, 47 y);
108 lesions
GPs took macro and dermoscopic
images and sent for teledermatology
diagnosis, compared with FTF
diagnosis by dermatologist
Diagnostic accuracy;
management
concordance; barriers,
image quality
3
Warshaw et al,29
2015
Cross-sectional,
repeated
measures study
United States;
2152 patients,
96.8% men
(mean age, 68 y);
3021 lesions
Macro and dermoscopic images
collected and sent to
teledermatologist; diagnosis
compared with FTF diagnosis
Diagnostic concordance;
management
concordance; barriers,
image quality
2
Wolf et al,18
2013
Case-control
diagnostic
accuracy study
United States;
188 images
of lesions from
clinical database
Images from database uploaded to
mobile application for
teledermatology diagnosis and
compared with histopathological
diagnosis
Diagnostic accuracy;
barriers, image quality
3
(continued)
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diagnosis and reference standard,11,27 and sensitivity and specific-
ity for detecting melanoma of 98% and 30%, respectively.18 Five
studies including dermoscopic or microscopic images of 69 to 613
lesions in teledermatology consultations reported agreement be-
tween 51% to92%11,27,35 (κ, 0.41-0.63),17 and sensitivity and speci-
ficity for detecting melanoma of 96% and 62%, respectively.10
One study reported very high sensitivity and specificity of
teledermatology for both malignant melanocytic lesions (sensitiv-
ity, 100%; specificity, 97%-98%;n = 6) andmalignantnonmelano-
cytic lesions(sensitivity,97%;specificity,92%-94%,n = 58), forboth
clinical and dermoscopic images (no significant differences
between thesemethods).11
Studies that compared the diagnostic accuracy of telederma-
tologywithFTFdiagnoses reportedvariable results. Levelsof agree-
mentbetweenteledermatologydiagnosesandhistopathologicaldi-
agnoses were comparable to levels of agreement between FTF
diagnoses and histopathological diagnoses in 1 study; 79% to 85%
for teledermatology (clinical images, 79%; dermoscopic images,
85%) and 85% for FTF.11 However, in a second study that com-
pared teledermatology and FTF primary diagnoses as well as ma-
lignant and/or benign categorization, the agreementwas lower for
teledermatology (51%-61% for TD vs 67% FTF for primary diagno-
ses, and 75%-80%for teledermatology and87%FTF for benign vs
malignant).35 A third study reported much lower agreement be-
tweentelediagnosisandhistopathologicaldiagnosis, comparedwith
FTF diagnosis and histopathological diagnosis (κ, 0.41-0.63 for TD,
κ, 0.90 for FTF).17
Four other studies reported diagnostic accuracy of telederma-
tology, without any comparisonwith FTF diagnoses. These studies
reportedagreementbetween telediagnosis and the reference stan-
dard of 51% to 100%.10,26,27,36When separatingmalignant andbe-
nign lesions, telediagnoses of malignant lesions were histopatho-
logicallyconfirmed in62%to100%ofcases,dependingonthestudy.
Of note, the study reporting 100% agreement between telediag-
nosis and histopathological diagnosis for malignant lesions only
included 8malignant lesions.26
Diagnostic Concordance
Ten included studies reported diagnostic concordance between
teledermatology and FTF clinical diagnoses (Table 4). These re-
sults were not histologically confirmed, so the FTF diagnosis is
considered the reference standard.
Three studies without dermoscopy reported diagnostic con-
cordancebetween62%and94%.Diagnostic concordance in stud-
ies includingdermoscopic images ranged from46%to90%forpri-
marydiagnoses,or71%to91%foraggregateddiagnostic categories.
There were significant differences in diagnostic concordance be-
tween teledermatology and FTF clinical diagnoses when the same
dermatologistperformedbothmethods(κ,0.95; range,0.91-0.99)16
compared with studies involving different dermatologists
(κ, 0.47-0.51).35
Of note, 1 study examined interobserver reliability between 5
teledermatologists and reported wide variation in levels of agree-
ment (κ, 0.38-0.97).28
Table 3. Study Characteristics (continued)
Source Design Population Intervention Outcome
Quality
Ratinga
Studies of enablers and barriers to implementation
Ferrandiz et al,38
2012
Descriptive
longitudinal
study
Spain; 201 patients,
52.4% women
(mean age, 57.5 y)
Teledermatology system used to
triage patients with suspicious
lesions; outcomes compared with
conventional referral system
Time, measured
as prognosis
3
Lim et al,30
2012
Prospective
observational
study of patient
flow
New Zealand; 100 FTF
patients, 36% men, (mean
age, 62.7 y); 200 virtual
lesion clinic patients,
39% men (mean age, 53 y)
Dermatologist triaged referrals to
be seen FTF or through virtual lesion
clinic; patient flow was compared
Time; barriers,
patient satisfaction
3
Morton et al,31
2010
Prospective
observational
study of patient
flow
Scotland; 289 patients
photo-triaged; 171 women,
118 men (mean age, 51 y);
188 conventional pathway,
93 women, 95 men
(mean age, 52 y)
Patients referred by GP by
conventional electronic letter or
through a dedicated skin cancer
standard referral form with
photographs taken at GP practice;
patient flow compared between
groups
Time 3
Spinks et al,32
2015
Discrete choice
experiment
Australia; participants from
a teledermoscopy trial;
35 participants;
aged 50-64 y
Participants who had used
consumer-driven teledermoscopy
completed a survey to investigate
preferences for melanoma screening
options
Barriers, patient
choices and
willingness to pay
3
Wu et al,33
2015
Prospective
cohort study
United States; 34 patients,
18 men, 16 women (aged
18-81 y; mean, 43.6 y);
29 patients with 33 lesions
completed follow-up
Patients took images of lesions at
baseline and follow-up and
completed surveys assessing skincare
awareness and attitudes toward
teledermoscopy
Barriers, difficulty
of image acquisition,
patient receptivity,
confidence
3
Abbreviations: FTF, face-to-face; GP, general practitioner; MMS, multimedia
messenger service.
a Quality rating scheme is modified from the Oxford Centre for Evidence-Based
Medicine ratings of individual studies: (1) Systematic review of cross-sectional
studies with consistently applied reference standard and blinding;
(2) individual cross-sectional studies with consistently applied reference
standard and blinding; (3) nonconsecutive studies, or studies without
consistently applied reference standards; (4) case-control studies, or poor or
nonindependent reference standard; (5) mechanism-based reasoning. Level
may be graded down on the basis of study quality, imprecision, indirectness
(study PICO [patient, intervention, comparison, outcome] does not match
questions PICO), because of inconsistency between studies, or because the
absolute effect size is very small; level may be graded up if there is a large or
very large effect size.34
Teledermatology for the Diagnosis andManagement of Skin Cancer Review Clinical Review& Education
jamadermatology.com (Reprinted) JAMADermatology March 2017 Volume 153, Number 3 323
Downloaded From:  by a UQ Library User  on 08/07/2018
Copyright 2017 American Medical Association. All rights reserved.
Quality of Diagnostic Accuracy and Diagnostic Concordance Studies
Most studiesofdiagnostic accuracyandconcordanceof telederma-
tologyhad significantmethodological limitations.Many studiesdid
not take (or report) adequate steps to reduce risk of selection bias,
whichcould leadtooverestimatingthediagnosticaccuracy (Table5).
Forexample,enrollinghigh-riskpatientsorexcluding low-quality im-
ages could lead to apparent higher sensitivity of teledermatology
than would be found in a general population group.
Table 4. Summary Table of Results for the Diagnostic Accuracy, Diagnostic Concordance, Treatment Accuracy, and Treatment Concordance
of Teledermatology for the Diagnosis of Skin Cancer
Reference Standard Index Test Intervention Results References
Diagnostic accuracy
Histopathology Teledermatology No dermoscopy Diagnostic agreement 68%; sensitivity,
% (95% CI): 98.1 (88.8-99.9); specificity,
% (95% CI): 98.3 (22.1-40.3)
Senel et al,27 2014; Wolf et al,
201318
Dermoscopy Diagnostic agreement 51%-92%; sensitivity,
96%; specificity, 62%
Borve et al,35 2013; Borve et al,36
2015; Senel et al,27 2014;
Congalton et al,10 2015
FTF No dermoscopy No studies
Dermoscopy Diagnostic agreement, 67% Borve et al,35 2013
Histopathology
(excised lesions) and
FTF diagnosis
(nonexcised lesions)
Teledermatology No dermoscopy Diagnostic agreement, 85% Kroemer et al,11 2011
Dermoscopy Diagnostic agreement, 79%-94%;
κ, 0.41-0.63
Kroemer et al,11 2011; Massone
et al,26 2014; Van der Heijden
et al,17 2013
FTF No dermoscopy No studies
Dermoscopy Diagnostic agreement, 85%; κ, 0.90 Kroemer et al,11 2011;
Van der Heijden et al,17 2013
Diagnostic concordance
FTF Teledermatology No dermoscopy Diagnostic concordance, 62%-94% Lamel et al,12 2012; Borve et al,35
2012; Silveira et al,15 2014
Dermoscopy Diagnostic concordance, 46%-90% Tan et al,16 2010; Borve et al,35
2013; Manahan et al,13 2015;
Warshaw et al,29 2015
Treatment accuracy
Histopathology Teledermatology No Dermoscopy Not reported
Dermoscopy 1 melanoma in situ would have received no
treatment (according to 1 TD); 100% of
invasive MM (n = 19) prioritized correctly;
100% of MM (n = 16) prioritized correctly
(at least medium)
Borve et al,35 2013; Borve et al,36
2015
Histopathology FTF No dermoscopy Not reported
Dermoscopy 3 of 4 invasive melanoma and 3 of 5
melanoma in situ incorrectly given
medium or low priority triage
Borve et al,36 2015
Treatment concordance
FTF Teledermatology No Dermoscopy Treatment concordance, 69%-95%;
κ, 0.23-0.57
Boyce et al,14 2011; Lamel et al,12
2012; Borve et al,37 2012
Dermoscopy Treatment concordance, 66%-85%;
κ, 0.19-0.83
Van der Heijden et al,17 2013;
Warshaw et al,29 2015; Senel
et al,27 2014
Abbreviations: FTF, face to face; MM,malignant melanoma; TD, teledermatologist.
Table 5. Summary of Recommendations for Teledermatology for the Diagnosis and Treatment of Skin Cancers
Recommendation
Grade of
Recommendationa
Quality of
Evidencea Source
Teledermatology should be used
for patients where it is not feasible
to provide FTF consultation.
2A B Borve et al,37 2012; Borve et al,35
2013; Borve et al,36 2015; Boyce et al,14
2011; Congalton et al,10 2015; Kroemer
et al,11 2011; Lamel et al,12 2012;
Manahan et al,13 2015; Massone et al,26
2014; Senel et al,27 2014; Silveira
et al,15 2014; Tan et al,16 2010; Tan
et al,28 2010; Van der Heijden et al,17
2013; Warshaw et al,29 2015; Wolf
et al,18 2013
Teledermatology can be used as a
triage tool to reduce waiting times
to assessment.
2A B Ferrandiz et al,38 2012; Lim et al,30
2012; Morton et al,31 2010; Borve
et al,36 2015
Currently available technology is
suitable for teledermatology
assessment. Training of clinicians and
consumers and/or patients should be
considered to improve image quality.
1 B Boyce et al,14 2011; Wolf et al,18 2013;
Silveira et al,15 2014; Borve et al,35
2013; Van der Heijden et al,17 2013;
Massone et al,26 2014; Manahan et al,13
2015; Warshaw et al,29 2015;
Wu et al,33 2015
Abbreviation: FTF, face-to-face.
a Graded according to criteria by
Robinson et al.39 Grade of
recommendation: 1, strong
recommendation: high-quality,
patient-oriented evidence; 2A, weak
recommendation: limited-quality,
patient-oriented evidence; 2B, weak
recommendation: low-quality
evidence. Quality of evidence:
A, systematic review/meta-analysis,
randomized clinical trials with
consistent findings, all-or-none
observational studies; B, systematic
review/meta-analysis of
lower-quality clinical trials or studies
with limitations and inconsistent
findings, lower-quality clinical trial,
cohort study, case-control study;
C, consensus guidelines, usual
practice, expert opinion, case series.
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Otherconcernswith increasedriskofbias includedstudieswhere
thesamedermatologistprovidedtheFTFandtelediagnosis; thismay
bias the indextest if thetelediagnosiswasprovidedfollowingtheFTF
diagnosis, or the reference standard, if vice versa (Table 5).
There were no systematic differences between the results of
studies that seemed tohave taken steps to reduce riskofbias, com-
pared with those with higher risk of bias. For example, there were
higher-quality studies that reportedbothhigher and lower levels of
diagnostic accuracy, and the same was true of studies with signifi-
cant limitations. This suggests the wide variation in results of diag-
nostic accuracy and concordance is not owing to 1 consistent iden-
tifiable type of bias, but rather is a owing to a combination of
methodological limitations in most studies in this field. These may
be actual limitations, or important aspects of study design omitted
in the reporting of studies, as evidenced by the large number of
unclear ratings (Table 1).
Accuracy of Clinical Management Plans
Only 2 recent studies35,36assessed the treatment accuracy of
teledermatology,35,36 measured by the level of agreement be-
tween recommended treatmentbasedon teledermatological diag-
nosis and histopathological diagnosis (Table 4). In 1 study,35 1mela-
noma insitu (1.5%,n = 69)wouldhave receivednotreatmentbased
onthe telediagnosis fromoneof thedermatologists in thestudy.The
second dermatologist in that study made adequate treatment de-
cisions in 100% of cases. The second study used teledermatology
as a triage tool. All 19patientswith invasivemelanomaandall 16pa-
tientswithmelanoma in situwereprioritized appropriately as high,
and at leastmediumpriority, respectively. In the same study, 3 of 4
patients with invasive melanomas and 3 of 5 patients with mela-
noma in situ referred by traditional paper referral were incorrectly
givenmedium or low priority, and low priority, respectively.
Concordance of Clinical Management Plans
Six studies (3 with dermoscopy and 3 without) examined treat-
ment concordance between teledermatology and FTF consulta-
tions (Table 4). Agreement between management plans (ie, deci-
sion toexcise lesions, review in short term, long term,or not review
at all) ranged from 66% to 85% (κ, 0.19-0.83).12,14,17,27,29,37
Time Involved in Teledermatology Consultations
Breslow Thickness
Onestudy including201participants reportedBreslow thicknessof
melanoma as an indicator of earlier diagnosis and reported lower
Breslowthickness in theteledermatologygroupcomparedwithcon-
ventional referral (1.06mm vs 1.64mm, P = .03).38
Waiting Time
Four studies examined theeffect of teledermatology consultations
on waiting times to FTF appointments, waiting time to diagnosis,
and/orwaitingtimetosurgery.Reductions inwaitingtimes inteleder-
matology groups were reported in all studies.
Three studies10,31,36 specifically reporting waiting times for pa-
tients with melanoma found patients in teledermatology groups
waitedsignificantly shorterperiods than thosewithconventional re-
ferrals. The actual average waiting periods varied significantly be-
tweenstudies, from9days(teledermatology)comparedwith14days
(paper referral), 9 days (teledermatology) vs 26.5 days (FTF clinic),
and 36 (photo triage) compared with 39 days (conventional refer-
ral). Patients who were referred using teledermatology triage sys-
tems more often received primary treatment in a single dermatol-
ogyappointmentandrequiredfewerappointmentsfortreatment.31,36
Patient Satisfaction and Barriers to Teledermatology
Eleven included studies explored patient satisfaction, clinician fac-
tors, and/or a range of barriers to teledermatology. The heteroge-
neous nature of these studies and the outcomemeasures allowed
only a descriptive summary.
Patient Satisfaction
Four studies examined measures of patient satisfaction, including
confidence and use of teledermatology, satisfaction with waiting
times, preferences, and willingness to pay.
In2of 11 studiesa total of55 (100%)consumers submitted their
own images (withandwithoutdermoscopy)andreportedtheywere
satisfiedwith theeaseofuse14andwilling topayout-of-pocketcosts
for teledermatology services.32Economicmodelingwasused toes-
timatewillingness topay,32 suggesting consumerswouldpayanav-
erage of A$110 to have teledermoscopy review as a health service
option, in addition to the currently available options of skin self-
examination,skincancerclinic,orgeneralpractitionerclinic.Thiscon-
ceptwas supported by aUS study that reported patientswerewill-
ing topay$20to$500foramobiledermatoscope(median,$100).33
Other benefits of teledermatology and teledermoscopy re-
ported by patients included shorter waiting times, more frequent
monitoring, and improvedprivacy andcomfort.One studymeasur-
ing patient satisfaction using a 5-point satisfaction scale reported
higher satisfactionwithwaiting times (2.9FTFvs4.0 teledermatol-
ogy) and overall satisfaction compared with FTF (3.8 FTF vs 4.5
teledermatology).30
Diagnostic Difficulty and Diagnostic Confidence
One study35 reported higher diagnostic difficulty for teledermatol-
ogy consultations vs FTF consultations. Clinicians using telederma-
tology reported61% to87%cases as highdifficulty comparedwith
the clinician seeing patients FTF, who reported 54% as high-
difficulty diagnoses. Another study examining diagnostic confi-
dence of clinicians found diagnostic agreement increased as the
clinicians diagnostic confidence increased.29
Image Quality
Studies14,15,17 reported up to 8%of images as being unevaluable or
unacceptablequality,but thisproportion increasedto36%badqual-
ity imageswhenclinicianswereasked to rate imagequality as good,
reasonable, or poor. Of note, a large study26 of 959 images found
telediagnosis was possible in 99.7% of cases, and only 1% of der-
moscopic and 4% of clinical images were rated as low quality.
Interobserver Reliability
Only 1 included study16 reported the interobserver reliability of
teledermatologists as moderate for diagnostic group (κ, 0.56-
0.78) and low for management plans (κ, 0.31-0.38).
Self-monitoring
An Australian study of 49 participants examining the introduction
of mobile dermoscopy into current skin self-examination recom-
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mendations reported barriers to effective self-monitoring.13 In this
study, the FTF dermatologist identified 40 lesions of concern on
25 people, which had not been identified during skin self-
examination. Of these 40 lesions, 24 did not meet the asymmetry
and color rule communicated to consumers as a method for iden-
tifyingconcerning lesions.However,noneof these lesionsweresub-
sequently diagnosed as melanoma.
Discussion
Fiveyearsafter the last systematic reviewof teledermatology for the
diagnosisandtreatmentofskinconditions, includingskincancer,7 the
conclusion remains the same; the accuracyof FTFdermatology con-
sultationisgenerallyhigherthanteledermatology.However,somestud-
ies in this reviewdidreporthighaccuracyof teledermatologydiagno-
sesforskincancer.Addressingthe limitationsofpreviousresearchwill
help todeterminewhether teledermoscopy isasafeandappropriate
alternativetoin-personassessment,whichisparticularly importantfor
countrieswithhighratesofskincancersandgeographicallydispersed
populations, includingAustralia and theUnited States.
Future researchers in this field should aim to overcome the
methodological limitations including lack of histopathology as ref-
erence standard, sample and diagnostic bias. A crossover trial of
teledermatology andFTFdiagnosis couldbebeneficial,with differ-
ent cliniciansproviding the teledermatology andFTFdiagnosis, be-
fore switching into the other arm. Carefully designed and rigorous
diagnostic studies could help to identify whether teledermatology
is equally or more accurate for diagnosing particular types of le-
sions, and whether the variation seen in accuracy of teledermatol-
ogy isowing todifferences in clinical opinions, or someaspectof the
teledermatology technology or process itself. Additional recom-
mendations based on this review are presented in Table 5.
A common challenge in studies of telemedicine interventions
is separating the effect of the intervention fromother factors influ-
encing theclinical outcomes.Themostmethodologically soundway
to test thediagnostic accuracyof teledermatologywouldbeassign-
ing different clinicians for the teleconsultations and FTF consulta-
tions, to prevent bias resulting from recall of the lesions and asso-
ciated diagnosis the second time they see them. However, it is
necessary to first ensure the clinicians havehigh inter-rater reliabil-
ity,whichmaybemore likelywhen clinicians havehad similar train-
ing and are equally as experienced as dermatologists.Without this,
it is very difficult to tell whether the limited agreement in diagno-
ses is relatedto theuseof the technology itself, ordifferences inclini-
cal opinionwhich could ordinarily exist in practice, as suggested by
thevariation in interobserver reliability reported in studies16,17 com-
paringdiagnoses andmanagementplans frommultipledermatolo-
gists and previous studies in dermatopathology.4-6
Thenomenclatureusedby clinicians and researchers can influ-
ence measures of accuracy. This has been recognized and is
currently being addressed by the International Skin Imaging
Collaboration.40 This aside, evendermatologists in the same coun-
trieswhohave receiveddifferent trainingmaydescribe the same le-
sion differently. If the researchers are not well versed in dermatol-
ogy terminology, this variation innomenclature could inadvertently
result in underestimation of diagnostic accuracy.
While diagnostic accuracy is important, its relevance is less-
ened as long as the patient receives the same treatment, for ex-
ample if the lesion is recommended for excision regardless. Studies
included in this review focusing on agreement betweenprescribed
managementplans fromteleconsultationsvsFTFconsultationssug-
gest themanagementplansprescribedby teledermatologistswere
appropriate, and only 1 missed case of melanoma in situ was re-
ported in 1 study.35Unfortunately all studieshad small sample sizes,
requiring confirmation in larger and more diverse samples. Impor-
tantly, when teledermatology was used as a triage tool, all mela-
nomaandmelanoma in situ caseswere correctly prioritized as high
priority, while a number of melanoma and melanoma in situ were
inappropriately triaged as medium or low priority using conven-
tional (nonteledermatology) referral pathways.
Very few studies (4 of 21) assessed health services outcomes
measures.10,31,36,38Those thatdid found theuseof teledermatology
could reducewaiting timesandresult inearlierassessmentandtreat-
ment, patients reportedhigh satisfactionandwerewilling topayout
ofpocket foraccess tosuchservices.Ontheotherhand,clinicians re-
portedhigherdiagnosticdifficultyforteledermatologycasescompared
withFTFconsultationsandlevelsofdiagnosticagreementwerefound
toberelatedtoclinician-reporteddiagnosticconfidence. It ispossible
thatwithmoreexperienceandexposuretoteledermatologycases,cli-
nicians’ increased confidencewith thismode of health care delivery
could result in improved accuracy. There were no studies assessing
longer-termoutcomeslikequalityof lifeorworkflowthatwerespecific
to skin cancer and eligible for inclusion in this review.
Authorsofa recentcommentary41 fromSpainproposedteleder-
matology be used primarily to improve referral and triage systems,
rather than replacing in-person consultations, owing to the current
lackofhigh-levelevidence tosupportdiagnosticaccuracyof teleder-
matology. The evidence from this review also supports the imple-
mentationof teledermatology as a referral and/or triage tool. How-
ever, the potential benefits to patients who currently have limited
access todermatological caresuggests there is reasonto investmore
resources todefinitivelyestablish thediagnosticaccuracyof teleder-
moscopy for skin cancer diagnosis.
Conclusions
Incorporating economic outcomemeasures into a larger diagnostic
studywouldenableconcurrentexplorationof themostsuitablemod-
els of care to integrate teledermatology into thediagnosis and treat-
ment of patients withmelanoma and nonmelanoma skin cancers.
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NOTABLENOTES
Hematoxylin in History—TheHeritage of Histology
Faisal R. Ali, MA, MRCP (Derm); Guy E. Orchard, PhD, MSc (Dist), FIBMS, CSci; RajeevMallipeddi, MD, FRCP
As staplesof thehistopathology laboratory, hematoxylin andeosinhave
become the inimitable scaffoldonwhichmanyofourdermatological di-
agnoses are made.
Hematoxylin (etymologicallyderived fromtheGreekhematos: blood
and xylos: tree) was originally derived from the heartwood (logwood)
of the treeHematoxylon campechianum, whose roots and trunk exude
a ruddy turbid colorantwhenboiledor steamed.1,2 Theproductwasdis-
covered by Spanish explorers in the Yucatan Peninsula (in modern
Mexico) in the 16thcentury.The indigenousMayahad longused it todye
cotton and to halt diarrhea.
Logwood was soon exported to Europe by the Spanish for use as a
textile colorant, attracting attentionandenvy, and it soonbecamea tar-
get of piracy,withEnglish, French, andDutch forces all seeking toprofit
from its use. Its value was such that Spain initially claimed a monopoly
on all logwood sales and later the right to profit from logwood planta-
tionswas part of the political settlement that followed the SevenYears’
War between Britain, France, and Spain (1754-1763).
Hematoxylinwasoriginallyusedasa fabricdyeandwasused to stain
theuniformsof soldiers in theAmericanCivilWar and subsequently the
First and SecondWorldWars. Its use as a dye underwent a renaissance
during theSecondWorldWarasallied forces sought sourcesofdyeother
thanGerman-manufacturedanilinedyes. Furthermore, it hasbeenused
as a paint in artwork.
Owing to its short-lived “fugitive” colorant effect, logwood was
initially outlawed in England during the Elizabethan era. Later, adding
a mordant derived from a heavy metal (eg, aluminum, iron, or tung-
sten) to make the color more permanent became an established prac-
tice. It is the mordant that increases the hematein’s (the basic dye
extract) affinity for nucleic acids and also defines the staining charac-
teristics of the hematoxylins used in pathology to this day. Thus,
hematoxylins are often classified according to the mordants they con-
tain, and examples include aluminum hematoxylins (Ehrlich, Delafield,
Mayer, Harris, Gill), iron hematoxylins (Heidenhain, Weigert, Verhoeff),
and tungsten hematoxylins (phosphotungsten acid hematoxylin) to
name but a few.
In 1879, Cook published one of the first protocols describing hema-
toxylin extraction for use in staining tissue, using an alum-copper ex-
traction process.3 Despite the advent of synthetic dyes, the use of he-
matoxylin for staining tissue has endured to the present, albeit with a
lower threat of piracy and use as a political bargaining tool.
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